Babylon Healthcare targets chronic disease in $100 million expansion

Air strike warning app helps Syrians dodge death from the skies
September 13, 2018
Trump’s antitrust enforcer considers shifting up a gear
September 13, 2018
This post was originally published on this site

Artificial intelligence company Babylon Health said it would invest $100 million to double its team of engineers and scientists in London and expand its capabilities to manage chronic diseases such as diabetes and depression.